Back
Commercial Metals 10K Form
Buy
54
CMC
Commercial Metals
Last Price:
60.44
Seasonality Move:
8.68%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-26 | 10Q | CMC/Commercial Metals Quarterly |
2024-01-08 | 10Q | CMC/Commercial Metals Quarterly |
2023-06-22 | 10Q | CMC/Commercial Metals Quarterly |
2023-03-23 | 10Q | CMC/Commercial Metals Quarterly |
2023-01-09 | 10Q | CMC/Commercial Metals Quarterly |
2022-06-22 | 10Q | CMC/Commercial Metals Quarterly |
Receive CMC News And Ratings
See the #1 stock for the next 7 days that we like better than CMC
CMC Financial Statistics
Sales & Book Value
Annual Sales: | $7.93B |
---|---|
Cash Flow: | $270.35M |
Price / Cash Flow: | 12.3 |
Annual Sales: | $37.68 |
Price / Book: | 1.6 |
Profitability
EPS (TTM): | 4.14000 |
---|---|
Net Income (TTM): | $485.49M |
Gross Margin: | $1.36B |
Return on Equity: | 11.49% |
Return on Assets: | 7.24% |
Commercial Metals Earnings Forecast
Key Commercial Metals Financial Ratios
- The Gross Profit Margin over the past 41 years for CMC is 17.14%.
- The Selling, General & Administrative Expenses for CMC have been equal to 8.39% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 9.86% of Operating Income.
- The Net Earning history of CMC is 6.13% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 21 years.
Commercial Metals Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Metals & Mining |
Sector: | Materials |
Current Symbol: | CMC |
CUSIP: | 201723 |
Website: | cmc.com |
Debt
Debt-to-Equity Ratio: | 0.28 |
---|---|
Current Ratio: | 3.94 |
Quick Ratio: | 2.42 |
Price-to-Earnings
Trailing P/E Ratio: | 14.6 |
---|---|
Forward P/E Ratio: | 12.67 |
CMC Technical Analysis vs Fundamental Analysis
Buy
54
Commercial Metals (CMC)
is a Buy
Is Commercial Metals a Buy or a Sell?
-
Commercial Metals stock is rated a Buy
The current Commercial Metals [CMC] share price is $60.44. The Score for CMC is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.